Pantoprazole sodium enteric-coated tablet and preparation method thereof

A technology for pantoprazole sodium tablet and pantoprazole sodium is applied in the directions of pharmaceutical formulations, medical preparations with inactive ingredients, medical preparations containing active ingredients, etc., and can solve problems such as non-compliance with quality control requirements and the like , to ensure the coating effect, improve product quality, and facilitate the effect of coating

Active Publication Date: 2015-03-04
HANGZHOU CONBA PHARMA
View PDF5 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It can be deduced from the patent that the specification of its enteric-coated tablet is 20mg, and its release behavior is compared with that of the original preparation developed by India Ruidi (India Ruidi’s product specification is 20mg, compared with Japan’s Takeda’s 40mg product, the dissolution curve is different), which belon

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pantoprazole sodium enteric-coated tablet and preparation method thereof
  • Pantoprazole sodium enteric-coated tablet and preparation method thereof
  • Pantoprazole sodium enteric-coated tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] The preparation of embodiment 1 pantoprazole sodium enteric-coated tablet

[0044] 1. Components and contents of pantoprazole sodium tablets

[0045] Name of raw material 1000 tablets (g) Proportion (%) effect Pantoprazole Sodium 44.3 35.00 Main drug Mannitol 44.00 34.76 filler microcrystalline cellulose 11.00 8.70 filler Sodium carboxymethyl starch (additional) 4.85 3.83 disintegrant Anhydrous Sodium Carbonate 9.56 7.55 stabilizer Crospovidone (additional) 9.71 7.67 disintegrant 16% povidone K30 50% ethanol solution 15.75 1.99 Adhesive Magnesium Stearate (additional) 0.63 0.50 lubricant

[0046] 2. The composition and content of the isolation layer

[0047] Excipient name Proportion (%) effect Hydroxypropylmethylcellulose 31.25 Gown material Titanium dioxide 18.75 Sunscreen talcum powder 50 Antisticking agent 50% ethanol Prepare 8% HP...

Embodiment 2

[0056] The preparation of embodiment 2 pantoprazole sodium enteric-coated tablets

[0057] (1) Components and content of pantoprazole sodium tablet

[0058] Name of raw material 1000 tablets (g) Proportion (%) effect Pantoprazole Sodium 44.3 45 Main drug Mannitol 14.77 15 filler microcrystalline cellulose 14.77 15 filler Sodium carboxymethyl starch (additional) 8.86 9 disintegrant Anhydrous Sodium Carbonate 4.92 5 stabilizer Crospovidone (additional) 8.86 9 disintegrant 16% povidone K30 50% ethanol solution 9.23 1.5 Adhesive Magnesium Stearate (additional) 0.49 0.5 lubricant

[0059] (2) The composition and content of the isolation layer

[0060]

[0061] The coating weight gain of the isolation layer is 6% of the plain tablet.

[0062] (3) Components and content of enteric-coated layer

[0063] Excipient name effect Udage L30D-55 Polymer solids are 18% of the...

Embodiment 3

[0067] The preparation of embodiment 3 pantoprazole sodium enteric-coated tablets

[0068] (1) Components and content of pantoprazole sodium tablet

[0069] Name of raw material 1000 pieces Proportion (%) effect Pantoprazole Sodium 44.3 35 Main drug Mannitol 52.14 41.2 filler microcrystalline cellulose 13.04 10.3 filler Sodium carboxymethyl starch (additional) 3.42 2.7 disintegrant magnesium oxide 6.33 5 stabilizer Crospovidone (internal addition) 6.83 5.4 disintegrant 2% povidone K30 50% ethanol solution 12.66 0.2 Adhesive Magnesium Stearate (additional) 0.25 0.2 lubricant

[0070] (2) The composition and content of the isolation layer

[0071] Excipient name Proportion (%) effect Hydroxypropylmethylcellulose 31.25 Gown material Titanium dioxide 18.75 Sunscreen Magnesium stearate 50 Antisticking agent 50% ethanol Prepare 6% HPMC50% ethanol s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a pantoprazole sodium enteric-coated tablet. The pantoprazole sodium enteric-coated tablet is prepared by coating a pantoprazole sodium tablet with an isolation layer and an enteric-coated layer, wherein the pantoprazole sodium tablet comprises the following components in percentage by weight: 35-45% of pantoprazole sodium, 30-59% of a filling agent, 0.2-3% of a binder, 8.1-18% of a disintegrant, 5-15% of a stabilizer and 0.2-1.5% of a lubricant. According to the pantoprazole sodium enteric-coated tablet and the preparation method thereof provided by the invention, a dissolution curve of the pantoprazole sodium enteric-coated tablet in each of four dissolution media is consistent with that of an originally developed preparation, thereby being in line with the requirements of consistency evaluation; and furthermore, the stability of the pantoprazole sodium enteric-coated tablet is better than that of the originally developed preparation.

Description

technical field [0001] The invention relates to the technical field of pharmaceutical preparations, in particular to a pantoprazole sodium enteric-coated tablet and a preparation method thereof. Background technique [0002] Pantoprazole sodium (trade name Pantoloc) is the third proton pump inhibitor listed after omeprazole and lansoprazole, due to the presence of pantoprazole sodium on the pyridine ring and benzimidazole ring The substituent group is different from omeprazole and lansoprazole, which determines its differences in biochemical, pharmacokinetic, pharmacological and other properties, making it more selective and different. That is, pantoprazole sodium can specifically inhibit the secretion of microtubules formed by the apical membrane of the parietal cells and the H on the tubular vesicles in the cytoplasm. + 、K + -ATPase, causing irreversible inhibition of the enzyme, thereby effectively inhibiting the secretion of gastric acid, not only non-competitively inh...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/32A61K9/36A61K31/4439A61K47/38A61K47/32A61K47/10A61P1/04
Inventor 徐春玲徐秀卉蒋国潮陈冠华宋远征王云蔚姚丽萍宋丹丹陈玲芳陆振宇
Owner HANGZHOU CONBA PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap